Australian Statistics on Medicines 2010

Table 1a - Nervous System

N01 - ANAESTHETICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANAESTHETICS
ANAESTHETICS, GENERAL
OPIOID ANAESTHETICS
N01AH01 FENTANYL
A 14186 Ampoule 100ug/2 5 — — 561 —
ANAESTHETICS, LOCAL
AMIDES
N01BB02 LIGNOCAINE HYDROCHLORIDE
A 15900 Ampoule 2% 2mL 50 — — 120 —
N01BB52 LIGNOCAINE with ADRENALINE
A 15905 Vial 2% 20mL 5 — — 164 —

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
NATURAL OPIUM ALKALOIDS
N02AA59 CODEINE with ASPIRIN
A 10090 Tablet soluble 8mg-300mg 20 — — 4,216 —
A 10091 Tablet soluble 8mg-300mg 100 — — 452 —
A 10466 Tablet soluble 8mg-500mg 24 — — 786 —
A 21158 Tablet soluble 9.5mg-500mg 24 — — 522 —
A 21174 Tablet soluble 8mg-300mg 40 — — 548 —
P 4061R Tablet soluble 8mg-300mg 50 — — 1,753 25,370
N02AA59 CODEINE with PARACETAMOL
A 11705 Capsule 8mg-500mg 50 — — 3,978 —
A 11706 Tablet 8mg-500mg 100 — — 14,134 —
A 11755 Tablet soluble 8mg-500mg 24 — — 2,895 —
P 1215Y Tablet 30mg-500mg 20 — — 2,532,289 20,737,079
A 12670 Tablet 8mg-500mg 20 — — 125 —
A 12736 Tablet 30mg-500mg 50 — — 1,898 —
A 14788 Tablet 8mg-500mg 100 — — 879 —
A 17212 Tablet 9.6mg-500mg 48 — — 1,376 —
A 17267 Caplet 8mg-500mg 48 — — 3,486 —
A 17819 Tablet 8mg-500mg 24 — — 4,467 —
A 17820 Tablet 8mg-500mg 48 — — 6,138 —
A 18373 Tablet 8mg-500mg 24 — — 12,012 —
A 18374 Tablet 8mg-500mg 48 — — 541 —
A 18375 Tablet 8mg-500mg 50 — — 241 —
A 18376 Tablet 8mg-500mg 96 — — 634 —
A 18377 Tablet 8mg-500mg 100 — — 1,668 —
A 18378 Tabsule 8mg-500mg 24 — — 862 —
A 18380 Tabsule 8mg-500mg 96 — — 110 —
A 18734 Tablet 15mg-500mg 12 — — 41,751 —
A 19039 Caplet 8mg-500mg 24 — — 8,505 —
A 19041 Tablet 8mg-500mg 24 — — 17,520 —
A 20658 Tablet 10mg-500mg 48 — — 193 —
A 21096 Tablet 9.6mg-500mg 36 — — 634 —
A 21097 Tablet 9.6mg-500mg 24 — — 9,517 —
A 21098 Tablet 9.6mg-500mg 12 — — 487 —
A 21111 Tablet 10mg-500mg 40 — — 7,019 —
A 21112 Tabsule 10mg-500mg 40 — — 250 —
A 21113 Tablet 10mg-500mg 40 — — 398 —
A 21146 Tablet 10mg-500mg 40 — — 425 —
A 21168 Tablet 8mg-500mg 40 — — 187 —
A 21173 Tablet 8mg-500mg 40 — — 424 —
A 21224 Tablet 10mg-500mg 40 — — 138 —
A 21225 Caplet 8mg-500mg 40 — — 2,481 —
A 21226 Tablet 8mg-500mg 40 — — 9,462 —

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
A 21227 Caplet 15mg-500mg 24 — — 6,621 —
A 21240 Tablet 10mg-500mg 24 — — 265 —
P 3316M Tablet 30mg-500mg 20 — — 150,246 1,212,413
P 4170L Tablet 15mg-500mg 20 — — 14,451 190,187
P 4171M Tablet 8mg-500mg — — 19,885 263,519
P 8785J Tablet 30mg-500mg 60 — — 993,983 17,398,031
N02AA08 DIHYDROCODEINE
A 11785 Linctus 200mL 1 — — 10,174 —
A 12825 Linctus 100mL 1 — — 5,818 —
N02AA03 HYDROMORPHONE
P 8420E Injection 2mg in 1mL 5 4.00 MG 3,548 173,811
P 8421F Injection 10mg in 1mL 5 4.00 MG 2,865 288,170
P 8422G Injection 50mg in 5mL 5 4.00 MG 2,147 304,537
P 8423H Injection 500mg in 50mL 4.00 MG 193 19,106
P 8424J Oral liquid 1mg per mL 473mL 20.00 MG 4,634 353,611
P 8541M Tablet 2mg 20 20.00 MG 2,249 56,563
P 8542N Tablet 4mg 20.00 MG 2,307 88,474
P 8543P Tablet 8mg 20.00 MG 2,565 222,311
P 9299K Tablet 4mg (modified release) 10 20.00 MG 6,307 221,215
P 9406C Tablet 8mg (modified release) 10 20.00 MG 9,020 427,476
P 9407D Tablet 16mg (modified release) 10 20.00 MG 7,787 535,885
P 9408E Tablet 32mg (modified release) 10 20.00 MG 4,571 535,427
P 9409F Tablet 64mg (modified release) 10 20.00 MG 2,534 745,708
N02AA01 MORPHINE
A 13087 Ampoule 5mg/mL 5 30.00 MG 3,168 —
A 14931 Capsule 20mg (sustained release) 100.00 MG 138 —
A 15415 Mixture 200mL 1mg per mL 100.00 MG 398 —
P 1607N Injection 120mg in 1.5mL 30.00 MG 2,929 414,685
P 1644M Injection 10mg in 1mL 30.00 MG 68,269 1,169,060
P 1645N Injection 15mg in 1mL 30.00 MG 13,097 313,153
P 1646P Tablet 30mg 100.00 MG 12,270 269,195
P 1647Q Injection 30mg in 1mL 30.00 MG 26,747 975,036
P 1653B Tablet 10mg (controlled release) 100.00 MG 74,573 2,057,720
P 1654C Tablet 30mg (controlled release) 100.00 MG 79,899 4,162,242
P 1655D Tablet 60mg (controlled release) 100.00 MG 62,864 5,251,476
P 1656E Tablet 100mg (controlled release) 100.00 MG 56,937 6,755,862
A 19608 Injection 10mg in 1mL 30.00 MG 123 —
A 19620 Injection 15mg in 1mL 30.00 MG 114 —
P 2122Q Oral solution 2mg per mL 200mL 100.00 MG 17,940 327,105
P 2123R Oral solution 5mg per mL 200mL 100.00 MG 28,563 617,346
P 2124T Oral solution 10mg per mL 200mL 100.00 MG 29,334 935,787
P 2839K Capsule 20mg (sustained release) 100.00 MG 49,895 1,958,565
P 2840L Capsule 50mg (sustained release) 100.00 MG 41,369 2,556,125

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
P 2841M Capsule 100mg (sustained release) 100.00 MG 31,114 3,733,899
P 3479D Injection 15mg in 1mL 30.00 MG 8,730 126,671
P 3480E Injection 30mg in 1mL 30.00 MG 3,840 61,343
P 8035X Tablet 5mg (controlled release) 100.00 MG 28,156 533,111
P 8146R Sachet 30mg (controlled release) 100.00 MG 1,122 95,495
P 8305D Sachet 60mg granules for oral suspn 100.00 MG 902 88,105
P 8306E Sachet 100mg granules for oral suspn 100.00 MG 384 56,958
P 8349K Capsule 10mg (sustained release) 20 100.00 MG 22,680 558,349
P 8453X Tablet 200mg (controlled release) 100.00 MG 718 243,986
P 8489T Tablet 15mg (controlled release) 20 100.00 MG 35,966 1,121,557
P 8490W Sachet 20mg granules for oral suspn 20 100.00 MG 2,629 212,607
P 8491X Capsule 30mg (controlled release) 10 100.00 MG 2,354 75,793
P 8492Y Capsule 60mg (controlled release) 10 100.00 MG 3,101 157,188
P 8493B Capsule 90mg (controlled release) 10 100.00 MG 2,518 184,513
P 8494C Capsule 120mg (controlled release) 10 100.00 MG 3,265 398,906
P 8669G Tablet 10mg 20 100.00 MG 1,062 16,943
P 8670H Tablet 20mg 20 100.00 MG 812 16,763
N02AA05 OXYCODONE
P 2481N Suppository 30mg 30.00 MG 9,844 887,243
P 2622B Tablet 5mg 75.00 MG 1,085,921 15,495,646
P 5195K Tablet 5mg 75.00 MG 1,123 13,702
P 8385H Tablet 10mg (controlled release) 20 75.00 MG 392,123 11,840,367
P 8386J Tablet 20mg (controlled release) 20 75.00 MG 334,317 17,689,338
P 8387K Tablet 40mg (controlled release) 20 75.00 MG 219,120 18,949,128
P 8388L Tablet 80mg (controlled release) 20 75.00 MG 126,427 17,403,019
P 8464L Capsule 5mg 20 75.00 MG 81,185 1,138,359
P 8501K Capsule 10mg 20 75.00 MG 108,966 2,343,355
P 8502L Capsule 20mg 20 75.00 MG 77,057 2,916,308
P 8644Y Oral solution 5mg per 5mL 250mL 75.00 MG 10,027 275,381
P 8681X Tablet 5mg (controlled release) 20 75.00 MG 203,043 5,405,529
P 9399Q Tablet 15mg (controlled release) 20 75.00 MG 60,631 2,426,466
P 9400R Tablet 30mg (controlled release) 20 75.00 MG 78,023 5,451,747
PHENYLPIPERIDINE DERIVATIVES
N02AB03 FENTANYL
P 5401G Lozenge 200ug 3 0.60 MG 783 225,109
P 5402H Lozenge 400ug 3 0.60 MG 330 107,076
P 5407N Lozenges 200ug (as citrate) 3 20 0.60 MG 270 198,432
P 5408P Lozenges 400ug (as citrate) 3 20 0.60 MG 204 151,864
P 5413X Lozenge 200ug 3 0.60 MG 366 312,566
P 5414Y Lozenge 400ug 3 0.60 MG 371 343,329
P 5415B Lozenge 600ug 3 0.60 MG 115 104,710
P 5416C Lozenge 800ug 3 0.60 MG 145 164,758
P 8878G Transdermal patch 2.1mg (12ug per hour) 5 1.20 MG 155,692 8,624,655

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
P 8891Y Transdermal patch 4.2mg (25ug per hour) 5 1.20 MG 177,366 12,258,905
P 8892B Transdermal patch 8.4mg (50ug per hour) 5 1.20 MG 110,947 13,464,219
P 8893C Transdermal patch 12.6mg (75ug per hour) 5 1.20 MG 55,704 9,262,902
P 8894D Transdermal patch 16.8mg (100ug per hour) 5 1.20 MG 55,315 12,686,214
N02AB02 PETHIDINE HYDROCHLORIDE
A 15888 Injection 100mg in 2mL 10 0.40 GM 2,389 —
A 18990 Injection 100mg in 2mL 0.40 GM 6,385 —
A 19593 Injection 50mg in 1mL 0.40 GM 887 —
A 19982 Injection 100mg in 2mL 5 0.40 GM 9,329 —
DIPHENYLPROPYLAMINE DERIVATIVES
N02AC04 DEXTROPROPOXYPHENE NAPSYLATE
P 4081T Capsule 100mg 0.30 GM 21,791 598,380
N02AC54 DEXTROPROPOXYPHENE with PARACETAMOL
A 16347 Capsule 32.5mg 325mg 20 — — 100,434 —
A 16444 Tablet 32.5mg 325mg 20 — — 359,383 —
A 16650 Tablet 32.5mg 325mg 20 — — 19,651 —
ORIPAVINE DERIVATIVES
N02AE01 BUPRENORPHINE
A 15207 Tablets 2mg (slow release) 1.20 MG 586 —
P 8865N Trans patch 5mg (release approx 5ug per hour) 2 1.20 MG 410,107 12,865,004
P 8866P Trans patch 10mg (release approx 10ug per hour) 1.20 MG 395,448 20,340,215
P 8867Q Trans patch 20mg (release approx 20ug per hour) 1.20 MG 226,826 17,965,382
OTHER OPIOIDS
N02AX02 TRAMADOL
P 2527B Tablet 50mg (twice daily sustained release) 20 0.30 GM 129,264 2,103,105
P 3484J Injection 100mg in 2mL 5 0.30 GM 15,656 223,774
P 5232J Capsule 50mg 20 0.30 GM 663 6,070
P 5234L Tablet 100mg (twice daily sustained release) 20 0.30 GM 226 3,093
P 5236N Tablet 200mg (twice daily sustained release) 20 0.30 GM 259 4,813
P 8455B Capsule 50mg 20 0.30 GM 134,910 1,249,008
P 8523N Tablet 100mg (twice daily sustained release) 20 0.30 GM 437,055 9,069,541
P 8524P Tablet 150mg (twice daily sustained release) 20 0.30 GM 214,572 6,011,786
P 8525Q Tablet 200mg (twice daily sustained release) 20 0.30 GM 380,246 12,667,176
P 8582Q Injection 100mg in 2mL 5 0.30 GM 10,582 150,680
P 8611F Capsule 50mg 20 0.30 GM 831,434 7,629,153
P 8843K Oral drops 100mg per mL 10mL 0.30 GM 3,389 78,823
P 9199E Tablet 100mg (once a day extended release) 0.30 GM 23,423 457,990
P 9200F Tablet 200mg (once a day extended release) 10 0.30 GM 25,975 750,563
P 9201G Tablet 300mg (once a day extended release) 10 0.30 GM 14,716 552,656
OTHER ANALGESICS AND ANTIPYRETICS
SALICYLIC ACID DERIVATIVES
N02BA01 ASPIRIN
P 1010E Tablet 300mg (dispersible) 3.00 GM 102,362 874,747

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
OTHER ANALGESICS AND ANTIPYRETICS
ANILIDES
N02BE51 METOCLOPRAMIDE and PARACETAMOL
A 18386 Tablet 5mg/500mg 24 — — 303 —
A 19053 Tablet 5mg/500mg 8 — — 2,368 —
A 19575 Capsule 5mg/500mg 10 — — 1,715 —
N02BE01 PARACETAMOL
A 11515 Tablet 500mg 50 3.00 GM 1,192 —
A 11516 Tablet 500mg 100 3.00 GM 268 —
A 11517 Tab-sol 500mg 24 3.00 GM 214 —
P 1746X Tablet 500mg 3.00 GM 555,142 4,640,151
P 1747Y Mixture 120mg per 5mL 100mL 3.00 GM 11,511 108,256
P 1770E Elixir 240mg per 5mL 200mL 3.00 GM 101,256 1,290,613
P 5196L Tablet 500mg 3.00 GM 221 1,793
P 5319Y Suppositories 500mg 24 3.00 GM 1,832 103,566
P 5320B Suppositories 500mg 24 3.00 GM 743 44,789
P 5343F Tablet 665mg (modified release) 9 6 3.00 GM 1,637 27,105
P 5344G Tablet 665mg (modified release) 9 6 3.00 GM 439 7,121
P 8784H Tablet 500mg 300 3.00 GM 1,211,799 14,883,678
P 8814X Tablet 665mg (modified release) 1 92 3.00 GM 2,977,467 49,264,227
N02BE51 PARACETAMOL with CODEINE with DOXYLAMINE
A 10870 Tablet 24 — — 5,335 —
A 12600 Tablet 20 — — 45,772 —
A 12932 Capsule 24 — — 1,717 —
A 13102 Tablet 20 — — 159,513 —
A 13200 Capsule 20 — — 182 —
A 13823 Capsule 20 — — 1,392 —
A 14177 Tablet 20 — — 44,907 —
A 14187 Tablet 20 — — 536 —
A 15650 Caplet 500mg-8mg-5mg — — 10,164 —
A 17268 Tablet 500mg-9.6mg-5.1mg 20 — — 4,058 —
A 21244 Tablet 450mg 9.75mg 5mg 24 — — 328 —
A 21251 Tablet 450mg 9.75mg 5mg 24 — — 212 —
N02BE51 PARACETAMOL with PROMETHAZINE with CODEINE
A 14779 Syrup 200mL 1 — — 3,173 —
A 18358 Syrup 120mg-6.5mg-5mg in 5mL 100mL — — 2,545 —
OTHERS ANALGESICS AND ANTIPYRETICS
N02BG09 METHOXYFLURANE
P 3489P Liquid for inhalation 999.9mg per g, 3mL (with inhaler) — — 9,585 429,222
ANTIMIGRAINE PREPARATIONS
ERGOT ALKALOIDS
N02CA01 DIHYDROERGOTAMINE
P 1323P Injection 1mg in 1mL 4.00 MG 1,522 38,195
P 3460D Injection 1mg in 1mL 4.00 MG 4,757 81,095

N02 - ANALGESICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANALGESICS
ANTIMIGRAINE PREPARATIONS
N02CA52 ERGOTAMINE TARTRATE with CAFFEINE
A 18569 Suppositories 2mg-100mg 5 — — 18,463 —
N02CA52 ERGOTAMINE with CAFFEINE
A 13550 Tablet 1mg-100mg 20 — — 489 —
N02CA04 METHYSERGIDE
P 2826R Tablet 1mg 4.00 MG 7,314 341,470
SELECTIVE 5HT RECEPTOR AGONISTS
N02CC06 ELETRIPTAN
P 5290K Tablet 40mg (as hydrobromide) 4 40.00 MG 975 23,735
P 5291L Tablet 80mg (as hydrobromide) 4 40.00 MG 384 9,123
N02CC02 NARATRIPTAN
P 8298R Tablet 2.5mg (as hydrochloride) 4 (2 upto Feb06) 2.50 MG 86,841 2,239,666
P 9734H Tablet 2.5mg (as hydrochloride) 4 2.50 MG 6,251 177,129
N02CC04 RIZATRIPTAN
P 9313E Wafer 10mg (as benzoate) 10.00 MG 36,209 902,366
N02CC01 SUMATRIPTAN
A 14181 Tablet 100mg 50.00 MG 14,187 —
A 15987 Nasal Spray 10mg per dose 2 20.00 MG 1,317 —
A 16720 Injection 6mg in 0.5mL refill 6.00 MG 1,405 —
A 16730 Injection 6mg in 0.5mL 6.00 MG 119 —
A 19640 Tablet 100mg 2 50.00 MG 279 —
A 19998 Tablet 100mg 2 50.00 MG 208 —
A 20306 Tablet 100mg 4 50.00 MG 528 —
A 20307 Tablet 50mg 2 50.00 MG 179 —
P 8144P Tablet 50mg (base) 4 (2 upto Feb06) 50.00 MG 363,768 9,008,650
P 8341B Nasal Spray 20mg per dose 2 20.00 MG 84,748 1,652,744
P 8885P Tablet (fast disintegrating) 50mg (as succinate) 4 50.00 MG 40,801 1,006,275
N02CC03 ZOLMITRIPTAN
P 8266C Tablet 2.5mg 4 (2 upto Feb06) 2.50 MG 127,772 3,291,430
P 9736K Tablet 2.5mg 4 2.50 MG 13,795 381,706
OTHER ANTIMIGRAINE PREPARATIONS
N02CX01 PIZOTIFEN MALATE
P 3074T Tablet 500ug (base) 1.50 MG 130,754 2,963,940

N03 - ANTIEPILEPTICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
BARBITURATES AND DERIVATIVES
N03AA02 PHENOBARBITONE
P 1850J Tablet 30mg 0.10 GM 14,762 227,503
P 1853M Injection 200mg in 1mL 0.10 GM 130 7,457
A 18751 Elixir 15mg/5mL 100mL 100.00 MG 174 —
N03AA03 PRIMIDONE
P 1939C Tablet 250mg 1.25 GM 15,853 1,319,272
HYDANTOIN DERIVATIVES
N03AB02 PHENYTOIN
P 1249R Tablet 50mg 0.30 GM 6,587 223,499
P 1873N Capsule 30mg 0.30 GM 19,943 577,722
P 1874P Capsule 100mg 0.30 GM 144,376 4,324,250
P 2692Q Paediatric oral suspension 30mg per 5mL 500mL 0.30 GM 9,879 304,899
SUCCINIMIDE DERIVATIVES
N03AD01 ETHOSUXIMIDE
P 1413J Capsule 250mg 1.25 GM 3,011 163,120
P 1414K Paediatric syrup 250mg per 5mL 250mL 1.25 GM 2,960 96,233
BENZODIAZEPINE DERIVATIVES
N03AE01 CLONAZEPAM
P 1805B Tablet 500ug 8.00 MG 33,662 673,085
P 1806C Tablet 2mg 8.00 MG 30,340 966,507
P 1807D Injection 1mg in 2mL (set containing solution) 8.00 MG 2,478 61,296
P 1808E Paediatric oral drops 2.5mg in 1mL 10mL 8.00 MG 5,548 94,847
P 3478C Oral liquid 2.5mg per mL 10mL 8.00 MG 1,620 17,385
P 5337X Tablet 500ug 8.00 MG 30,895 511,747
P 5338Y Tablet 2mg 8.00 MG 5,993 150,947
P 5339B Oral liquid 2.5mg per mL 10mL 8.00 MG 8,545 134,500
P 5340C Tablet 500ug 8.00 MG 15,328 243,452
P 5341D Tablet 2mg 8.00 MG 5,945 158,457
P 5342E Oral liquid 2.5mg per mL 10mL 8.00 MG 815 13,011
CARBOXAMIDE DERIVATIVES
N03AF01 CARBAMAZEPINE
P 2419H Tablet 200mg 1.00 GM 121,613 3,665,244
P 2422L Tablet 100mg 1.00 GM 52,591 998,697
P 2426Q Tablet 200mg (controlled release) 1.00 GM 73,759 2,257,158
P 2427R Oral suspension 100mg per 5mL 300mL 1.00 GM 24,023 695,037
P 2431Y Tablet 400mg (controlled release) 1.00 GM 54,776 2,785,728
P 5039F Tablet 100mg 1.00 GM 111 1,898
N03AF02 OXCARBAZEPINE
P 8584T Tablet 150mg 100 1.00 GM 1,903 144,226
P 8585W Tablet 300mg 100 1.00 GM 7,140 903,734
P 8586X Tablet 600mg 100 1.00 GM 4,746 945,585
P 8588B Oral suspension 60mg per mL 250mL 1.00 GM 1,136 162,166

N03 - ANTIEPILEPTICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
FATTY ACID DERIVATIVES
N03AG01 SODIUM VALPROATE
P 2289L Tablet 200mg (enteric coated) 200 1.50 GM 278,359 9,097,697
P 2290M Tablet 500mg (enteric coated) 200 1.50 GM 321,778 18,030,741
P 2293Q Oral liquid 200mg per 5mL 300 mL 1.50 GM 56,709 2,216,697
P 2294R Crushable tablet 100mg 1.50 GM 59,176 2,001,298
P 2295T Syrup 200mg per 5mL 300mL 1.50 GM 16,285 638,991
N03AG06 TIAGABINE
P 8221Q Tablet 5mg (base) 30.00 MG 745 64,641
P 8222R Tablet 10mg (base) 30.00 MG 915 149,484
P 8223T Tablet 15mg (base) 30.00 MG 339 66,743
N03AG04 VIGABATRIN
P 2667J Tablet 500mg 120 2.00 GM 7,749 1,068,355
P 2668K Oral powder sachet 500mg 2.00 GM 2,271 227,886
OTHER ANTIEPILEPTICS
N03AX12 GABAPENTIN
P 1834M Capsule 300mg 100 1.80 GM 78,836 5,530,885
P 1835N Capsule 400mg 100 1.80 GM 19,238 1,976,113
P 4591P Capsule 100mg 100 1.80 GM 6,023 163,527
P 4592Q Capsule 300mg 100 1.80 GM 12,350 889,318
P 4593R Capsule 400mg 100 1.80 GM 1,539 140,279
P 4594T Tablet 600mg 100 1.80 GM 1,413 210,799
P 4595W Tablet 800mg 100 1.80 GM 487 86,688
P 8389M Tablet 800mg 100 1.80 GM 11,675 2,173,171
P 8505P Capsule 100mg 100 1.80 GM 31,031 767,491
P 8559L Tablet 600mg 100 1.80 GM 16,968 2,353,284
N03AX18 LACOSAMIDE
P 9333F Tablet 50mg 14 0.30 GM 1,370 149,098
P 9335H Tablet 100mg 56 0.30 GM 2,729 565,237
P 9337K Tablet 150mg 56 0.30 GM 414 112,857
P 9338L Tablet 200mg 56 0.30 GM 779 277,512
N03AX09 LAMOTRIGINE
P 2848X Tablet 25mg 0.30 GM 42,990 1,498,572
P 2849Y Tablet 50mg 0.30 GM 78,658 3,871,724
P 2850B Tablet 100mg 0.30 GM 130,861 9,925,032
P 2851C Tablet 200mg 0.30 GM 94,744 11,386,301
P 8063J Tablet 5mg 0.30 GM 4,522 105,337
N03AX14 LEVETIRACETAM
P 8654L Tablet 250mg 60 1.50 GM 33,414 2,212,267
P 8655M Tablet 500mg 60 1.50 GM 99,755 11,129,768
P 8656N Tablet 1gm 60 1.50 GM 51,349 8,517,854
P 9169N Oral solution 100mg per mL 300mL 1.50 GM 6,086 793,991
P 9708Y Tablet 250mg 60 1.50 GM 5,054 420,336

N03 - ANTIEPILEPTICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
NERVOUS SYSTEM
ANTIEPILEPTICS
ANTIEPILEPTICS
P 9709B Tablet 500mg 60 1.50 GM 16,947 2,362,552
P 9710C Tablet 1gm 60 1.50 GM 10,430 2,092,063
N03AX16 PREGABALIN
P 4320J Capsules 25mg 56 0.30 GM 9,199 386,172
P 4322L Capsules 75mg 56 0.30 GM 110,987 10,077,848
P 4323M Capsules 150mg 56 0.30 GM 58,104 7,652,194
P 4324N Capsules 300mg 56 0.30 GM 19,844 3,776,264
N03AX03 SULTHIAME
P 2099L Tablet 50mg 0.40 GM 1,232 57,166
P 2100M Tablet 200mg 0.40 GM 1,524 150,217
N03AX11 TOPIRAMATE
P 8163P Tablet 25mg 0.30 GM 63,740 2,910,157
P 8164Q Tablet 50mg 0.30 GM 76,538 5,225,488
P 8165R Tablet 100mg 0.30 GM 44,458 4,523,372
P 8166T Tablet 200mg 0.30 GM 22,296 3,926,847
P 8371N Capsule 15mg 0.30 GM 1,497 74,853
P 8372P Capsule 25mg 0.30 GM 1,863 94,867
P 8520K Capsule 50mg 0.30 GM 2,371 215,502
Last updated
1 January 2010